RAFFA WEALTH MANAGEMENT, LLC’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
SFA
GT
S
BP
FRA
BCAM
QCM
AI
RAFFA WEALTH MANAGEMENT, LLC's RDY Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC increased its Dr. Reddy's Laboratories (RDY) stake by 69% in Q2 2026, buying an estimated $3.76K and bringing the position to 683 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #430.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in RDY in Q1 2021 and has held it in 22 quarters since. 51 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 683 shares of Dr. Reddy's Laboratories worth $9.9K as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC bought 279 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.76K.
- Dr. Reddy's Laboratories made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #430 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Dr. Reddy's Laboratories in Q1 2021 and has held it in 22 quarters since.
- 51 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.